Literature DB >> 8520200

Induced hypoestrogenism increases the arterial resistance index of leiomyomata without affecting uterine or carotid arteries.

C Y Spong1, R Sinow, R Renslo, E Cabus, J Rutgers, O A Kletzky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520200     DOI: 10.1007/BF02213716

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  5 in total

1.  Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin.

Authors:  W H Matta; I Stabile; R W Shaw; S Campbell
Journal:  Fertil Steril       Date:  1988-06       Impact factor: 7.329

2.  Long-term effects of hormone replacement therapy on the uterus and on uterine circulation.

Authors:  J P Pirhonen; M H Vuento; J I Mäkinen; T A Salmi
Journal:  Am J Obstet Gynecol       Date:  1993-02       Impact factor: 8.661

3.  A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.

Authors:  W D Schlaff; E A Zerhouni; J A Huth; J Chen; M D Damewood; J A Rock
Journal:  Obstet Gynecol       Date:  1989-12       Impact factor: 7.661

4.  An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.

Authors:  B R Carr; P B Marshburn; P T Weatherall; K D Bradshaw; N A Breslau; W Byrd; M Roark; M P Steinkampf
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

5.  Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.

Authors:  G S Letterie; C C Coddington; C A Winkel; T H Shawker; D L Loriaux; R L Collins
Journal:  Fertil Steril       Date:  1989-06       Impact factor: 7.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.